Form D · Venture Capital Fund

SV8 Biotech Fund LP

London, X0 · CIK 0002070013

Offering snapshot reported Jun 29, 2026 · SEC filing

Reported sold
$70M
Indefinite offering
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 16, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 29, 2026Amendment$70,000,000No comparison3SEC filing
Jun 12, 2025InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0
Form D file number
021-548769
All offering and sales information in Items 13 and 14 include only U.S. sales made pursuant to Regulation D.
Northern Lights operates under exemption from U.S. broker-dealer registration set forth in SEC Rule 15a-6, with Foreside Global Services, LLC, a U.S. broker-dealer registered with the SEC providing Chaperoning Services to Northern Lights for this Fund.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Northern Lights Alternative Advisors LLPNoneForeside Global Services, LLC · CRD 147382

Source: Form D, filed Jun 29, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

SV8 BIOTECH FUND LP

Investment adviser: SV HEALTH MANAGERS LLP

Gross asset value
$0
Beneficial owners
14
ADV minimum commitment
$10M

Reported in Form ADV on Mar 24, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator AZTEC FINANCIAL SERVICES (UK) LIMITED FAREHAM, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor RSM UK AUDIT LLP LONDON, United Kingdom
Custodian AZTEC FINANCIAL SERVICES (UK) LIMITED FAREHAM, United Kingdom Related to adviser: No
Custodian BARCLAYS BANK PLC LONDON, United Kingdom Related to adviser: No
Marketer NORTHERN LIGHTS ALTERNATIVE ADVISORS LLP LONDON, United Kingdom Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

RSM UK AUDIT LLP
PCAOB 1545

BARCLAYS BANK PLC
LEI G5GSEF7VJP5I7OUK5573

Filing source

Form ADV 2073234 · Mar 24, 2026 · Schedule D 7.B.(1), fund 805-5392438986

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kate Bingham Executive
James Costine Executive
Sv8 Bio Gp Llp Director, Executive
Sv Health Managers Llp Director, Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
71 Kingsway
London, X0, WC2B 6ST